Saliba F et al. |
Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial. |
2017 |
Am. J. Transplant. |
pmid:28133906
|
Sukkha S et al. |
Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study. |
2017 |
Int J Clin Pharm |
pmid:29101615
|
Elens L and Haufroid V |
Genotype-based tacrolimus dosing guidelines: with or without CYP3A4*22? |
2017 |
Pharmacogenomics |
pmid:29095105
|
Al-Uzri A et al. |
Longitudinal study on the use of dried blood spots for home monitoring in children after kidney transplantation. |
2017 |
Pediatr Transplant |
pmid:28635157
|
Ma X et al. |
Inhibition effect of tacrolimus and platelet-derived growth factor-BB on restenosis after vascular intimal injury. |
2017 |
Biomed. Pharmacother. |
pmid:28633129
|
Ekman-Joelsson BM et al. |
Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review. |
2017 |
Cardiol Young |
pmid:28780922
|
Ferreira A et al. |
Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus. |
2017 |
Am. J. Nephrol. |
pmid:28511172
|
Undre N and Dickinson J |
Relative bioavailability of single doses of prolonged-release tacrolimus administered as a suspension, orally or via a nasogastric tube, compared with intact capsules: a phase 1 study in healthy participants. |
2017 |
BMJ Open |
pmid:28377389
|
Forns X et al. |
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study. |
2017 |
Transpl Infect Dis |
pmid:28295849
|
Xie Y et al. |
Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance. |
2017 |
Transplantation |
pmid:28187014
|
Wang J et al. |
The correlation between the expression of genes involved in drug metabolism and the blood level of tacrolimus in liver transplant receipts. |
2017 |
Sci Rep |
pmid:28611384
|
Liu MZ et al. |
IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients. |
2017 |
Acta Pharmacol. Sin. |
pmid:28112181
|
Nishiya Y et al. |
A new efficient method of generating photoaffinity beads for drug target identification. |
2017 |
Bioorg. Med. Chem. Lett. |
pmid:28108248
|
Noguchi A et al. |
Differences in therapeutic effects of topically applied corticosteroid and tacrolimus on atopic dermatitis-like symptoms in NC/Nga mice. |
2017 |
J. Dermatol. Sci. |
pmid:28069324
|
MartÃn-Fernández M et al. |
Effects of Cyclosporine, Tacrolimus, and Rapamycin on Osteoblasts. |
2017 |
Transplant. Proc. |
pmid:29149986
|
Nakamura K et al. |
AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts. |
2017 |
Eur. J. Pharmacol. |
pmid:27993641
|
Lewis DJ et al. |
Oral bexarotene for post-transplant cutaneous T-cell lymphoma. |
2017 |
Dermatol Ther |
pmid:28748653
|
Chen P et al. |
Dynamic effects of CYP3A5 polymorphism on dose requirement and trough concentration of tacrolimus in renal transplant recipients. |
2017 |
J Clin Pharm Ther |
pmid:27885697
|
Grinyó JM et al. |
Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial. |
2017 |
Am. J. Kidney Dis. |
pmid:27889299
|
Zhang W et al. |
Isoglycyrrhizinate Magnesium Enhances Hepatoprotective Effect of FK506 on Ischemia-Reperfusion Injury Through HMGB1 Inhibition in a Rat Model of Liver Transplantation. |
2017 |
Transplantation |
pmid:28885495
|